Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 22
Filter
Add more filters










Publication year range
1.
Eur Neuropsychopharmacol ; 82: 82-91, 2024 May.
Article in English | MEDLINE | ID: mdl-38508100

ABSTRACT

INTRODUCTION: The study addresses concerns about potential psychiatric side effects of Glucagon-like peptide-1 receptor agonists (GLP-1 RA). AIM: The aim of this work was to analyse adverse drug reports (ADRs) from the Food and Drug Administration Adverse Events Reporting System (FAERS) using metformin and orlistat as comparators. METHODS: Descriptive and pharmacovigilance disproportionality analyses was performed. RESULTS: A total of 209,354 ADRs were reported, including 59,300 serious cases. Of those, a total of 5378 psychiatric disorder cases, including 383 'serious' cases related to selected ADRs were registered during 2005-2023. After unmasking, 271 cases where individual GLP-1 RA were implicated showing liraglutide (n = 90; Reported Odds Ratio (ROR) = 1.64), exenatide (n = 67; ROR = 0.80), semaglutide (n = 61; ROR = 2.03), dulaglutide (n = 45; ROR = 0.84), tirzepatide (n = 5; ROR = 1.76) and albiglutide (n = 2; ROR = 0.04). A greater association between these ADRs with metformin was observed, but not orlistat. With regards to selected preferred terms (PTs), 42 deaths including 13 completed suicides were recorded. Suicidal ideation was recorded in n = 236 cases for 6/7 GLP-1 RA (excluding lixisenatide). DISCUSSION: Suicide/self-injury reports pertaining to semaglutide; tirzepatide; and liraglutide were characterised, although lower than metformin. It is postulated that rapid weight loss achieved with GLP-1 RA can trigger significant emotional, biological, and psychological responses, hence possibly impacting on suicidal and self-injurious ideations. CONCLUSIONS: With the current pharmacovigilance approach, no causality link between suicidal ideation and use of any GLP-1 RA can be inferred. There is a need for further research and vigilance in GLP-1 RA prescribing, particularly in patients with co-existing psychiatric disorders.


Subject(s)
Anti-Obesity Agents , Glucagon-Like Peptide-1 Receptor , Pharmacovigilance , Self-Injurious Behavior , Suicidal Ideation , Humans , Glucagon-Like Peptide-1 Receptor/agonists , Male , Female , Adult , Middle Aged , Self-Injurious Behavior/epidemiology , Anti-Obesity Agents/adverse effects , Anti-Obesity Agents/therapeutic use , Adverse Drug Reaction Reporting Systems/statistics & numerical data , Metformin/adverse effects , Metformin/therapeutic use , Weight Loss/drug effects , Aged , Liraglutide/therapeutic use , Liraglutide/adverse effects , Orlistat/adverse effects , Hypoglycemic Agents/adverse effects , Hypoglycemic Agents/therapeutic use , Exenatide/therapeutic use , Exenatide/adverse effects , Young Adult , Glucagon-Like Peptide-1 Receptor Agonists
2.
Expert Rev Clin Pharmacol ; 16(11): 1109-1123, 2023.
Article in English | MEDLINE | ID: mdl-37968919

ABSTRACT

INTRODUCTION: The renewed interest in considering a range of stimulants, psychedelics and dissociatives as therapeutics emphasizes the need to draft an updated overview of these drugs' clinical and pharmacological issues. AREAS COVERED: The focus here was on: stimulants (e.g. amphetamines, methamphetamine, and pseudoephedrine; phenethylamines; synthetic cathinones; benzofurans; piperazines; aminoindanes; aminorex derivatives; phenmetrazine derivatives; phenidates); classical (e.g. ergolines; tryptamines; psychedelic phenethylamines), and atypical (e.g. PCP/ketamine-like dissociatives) psychedelics.Stimulant and psychedelics are associated with: a) increased central DA levels (psychedelic phenethylamines, synthetic cathinones and stimulants); b) 5-HT receptor subtypes' activation (psychedelic phenethylamines; recent tryptamine and lysergamide derivatives); and c) antagonist activity at NMDA receptors, (phencyclidine-like dissociatives). EXPERT OPINION: Clinicians should be regularly informed about the range of NPS and their medical, psychobiological and psychopathological risks both in the acute and long term. Future research should focus on an integrative model in which pro-drug websites' analyses are combined with advanced research approaches, including computational chemistry studies so that in vitro and in vivo preclinical studies of index novel psychoactives can be organized. The future of psychedelic research should focus on identifying robust study designs to convincingly assess the potential therapeutic benefits of psychedelics, molecules likely to present with limited dependence liability levels.


Subject(s)
Central Nervous System Stimulants , Hallucinogens , Methamphetamine , Humans , Hallucinogens/pharmacology , Psychotropic Drugs/pharmacology , Central Nervous System Stimulants/pharmacology , Phenethylamines
3.
Gynecol Oncol Rep ; 39: 100920, 2022 Feb.
Article in English | MEDLINE | ID: mdl-35036509

ABSTRACT

Mullerian adenosarcomas are rare and often low-grade mixed tumors that typically respond well to optimal surgical resection. However, adenosarcoma with sarcomatous overgrowth (ASSO) is a high-grade mixed tumor commonly associated with invasion, metastasis, and a poor prognosis. The health care providers herein report a case study of a patient diagnosed with ASSO who has maintained remission status for 19 months following radical surgical resection alone. The patient, a 24-year-old Caucasian female without significant medical history, initially complained of abdominal fullness, pelvic pressure, altered menses, and unintentional weight loss. A necrotic cervical mass was present on the exam; mass biopsy revealed spindle cell sarcoma with rhabdomyosarcomatous differentiation. The patient underwent exploratory laparotomy, total abdominal hysterectomy, bilateral salpingectomy, radical tumor debulking, and pelvic and periaortic lymph node dissection. Histopathological diagnosis of the resected specimen was consistent with ASSO, limited to 0.7 cm out of 2.0 cm of myometrial thickness, with negative lymph node and parametrial tissue, consistent with Stage IB disease. She did not receive adjuvant chemotherapy or radiation and has remained disease-free to date. Because of the rarity of ASSO and lack of abundant case study reports, uniform clinical guidelines for treatment following surgical resection of a high-grade adenosarcoma remain unclear. However, the case study below may suggest that radical surgical debulking of this disease with negative margins in young patients with early-stage disease can be sufficient in treating high-grade ASSO, despite their typical aggressive nature.

5.
Psychol Med ; 51(1): 30-42, 2021 01.
Article in English | MEDLINE | ID: mdl-31327332

ABSTRACT

BACKGROUND: The present paper provides an updated review of both the large number of new/novel/emerging psychoactive substances (NPS) and their associated psychopathological consequences. Focus was here given on identification of those NPS being commented in specialised online sources and the related short-/long-term psychopathological and medical ill-health effects. METHODS: NPS have been identified through an innovative crawling/navigating software, called the 'NPS.Finder®', created in order to facilitate the process of early recognition of NPS online. A range of information regarding NPS, including chemical and street names; chemical formula; three-dimensional image and anecdotally reported clinical/psychoactive effects, were here made available. RESULTS: Using the 'NPS.Finder®' approach, a few thousand NPS were here preliminarily identified, a number which is about 4-fold higher than those figures suggested by European and international drug agencies. NPS most commonly associated with the onset of psychopathological consequences included here synthetic cannabinoids/cannabimimetics; new synthetic opioids; ketamine-like dissociatives; novel stimulants; novel psychedelics and several prescription and over-the-counter medicines. CONCLUSIONS: The ever-increasing changes in terms of recreational psychotropics' availability represent a relatively new challenge for psychiatry, as the pharmacodynamics and pharmacokinetics of many NPS have not been thoroughly understood. Health/mental health professionals should be informed about the range of NPS; their intake modalities; their psychoactive sought-after effects; the idiosyncratic psychotropics' combinations and finally, their medical and psychopathological risks.


Subject(s)
Illicit Drugs/adverse effects , Illicit Drugs/pharmacology , Psychotropic Drugs/adverse effects , Psychotropic Drugs/pharmacology , Substance-Related Disorders/psychology , Humans , Psychopathology , Recreational Drug Use/psychology
6.
Cell Death Differ ; 23(6): 1049-59, 2016 06.
Article in English | MEDLINE | ID: mdl-26742432

ABSTRACT

Myelodysplastic syndrome (MDS) is characterized by ineffective hematopoiesis with resultant cytopenias. Increased apoptosis and aberrantly functioning progenitors are thought to contribute to this phenotype. As is the case for other malignancies, overcoming apoptosis is believed to be important in progression toward acute myeloid leukemia (AML). Using the NUP98-HOXD13 (NHD13) transgenic mouse model of MDS, we previously reported that overexpression of the anti-apoptotic protein BCL2, blocked apoptosis and improved cytopenias, paradoxically, delaying leukemic progression. To further understand this surprising result, we examined the role of p53 and its pro-apoptotic effectors, PUMA and NOXA in NHD13 mice. The absence of p53 or PUMA but not NOXA reduced apoptosis and expanded the numbers of MDS-repopulating cells. Despite a similar effect on apoptosis and cell numbers, the absence of p53 and PUMA had diametrically opposed effects on progression to AML: absence of p53 accelerated leukemic progression, while absence of PUMA significantly delayed progression. This may be explained in part by differences in cellular responses to DNA damage. The absence of p53 led to higher levels of γ-H2AX (indicative of persistent DNA lesions) while PUMA-deficient NHD13 progenitors resolved DNA lesions in a manner comparable to wild-type cells. These results suggest that targeting PUMA may improve the cytopenias of MDS without a detrimental effect on leukemic progression thus warranting further investigation.


Subject(s)
Apoptosis Regulatory Proteins/metabolism , Apoptosis , Myelodysplastic Syndromes/pathology , Tumor Suppressor Proteins/metabolism , Animals , Apoptosis Regulatory Proteins/genetics , Bone Marrow Transplantation , DNA Damage , Disease Models, Animal , Disease Progression , Hematopoietic Stem Cells/cytology , Hematopoietic Stem Cells/metabolism , Humans , Kaplan-Meier Estimate , Leukemia, Myeloid, Acute/metabolism , Leukemia, Myeloid, Acute/pathology , Mice , Mice, Inbred C57BL , Mice, Knockout , Mice, Transgenic , Myelodysplastic Syndromes/metabolism , Myelodysplastic Syndromes/mortality , Oncogene Proteins, Fusion/genetics , Phenotype , Proto-Oncogene Proteins c-bcl-2/genetics , Proto-Oncogene Proteins c-bcl-2/metabolism , Tumor Suppressor Protein p53/deficiency , Tumor Suppressor Protein p53/genetics , Tumor Suppressor Protein p53/metabolism , Tumor Suppressor Proteins/genetics
7.
Microvasc Res ; 78(1): 40-4, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19327373

ABSTRACT

Apoptosis is involved in the development and progression of atherosclerotic lesions. Protein kinase C (PKC) signalling is of importance in atherosclerosis as well as apoptosis. Therefore, we tested the involvement of PKC in lipid-induced apoptosis of human coronary artery endothelial cells (HCAEC). Protein expression of PKC isoforms alpha, beta I, delta, epsilon, and iota was detected, whereas no relevant protein amounts of PKC isoforms beta II, gamma, eta, theta, and zeta were found. Inhibition of classical and novel PKC isoforms by treatment with bisindolylmaleimide or PKC down-regulation by long-term treatment with 12-O-tetradecanoyl phorbol-13-acetate (TPA) could not prevent apoptosis induced by palmitate or stearate. In contrast, a specific myristoylated, cell-permeable PKC zeta/iota pseudosubstrate prevented lipid-induced apoptosis in HCAEC. Furthermore, saturated fatty acids activated PKC iota as evidenced by PKC iota down-regulation upon long-term treatment with stearate. Our data provide evidence that PKC iota is activated by saturated fatty acids and mediates lipid-induced apoptosis of HCAEC.


Subject(s)
Apoptosis/drug effects , Coronary Vessels/cytology , Endothelial Cells/metabolism , Endothelium, Vascular/metabolism , Isoenzymes/metabolism , Protein Kinase C/metabolism , Apoptosis/genetics , Cells, Cultured , Dose-Response Relationship, Drug , Endothelium, Vascular/cytology , Enzyme Activation , Fatty Acids/pharmacology , Humans , Isoenzymes/antagonists & inhibitors , Isoenzymes/genetics , Protein Kinase C/antagonists & inhibitors , Protein Kinase C/genetics
8.
Diabetologia ; 50(10): 2097-106, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17701023

ABSTRACT

AIMS/HYPOTHESIS: AMP-activated protein kinase (AMPK) is a heterotrimeric enzyme that acts as an intracellular fuel sensor, directing multiple metabolic pathways in a catabolic direction in times of nutrient shortage. In humans, three different gamma-subunits (gamma(1), gamma(2), gamma(3)) have been identified as AMPK regulators. The AMPKgamma3 (protein kinase, AMP-activated, gamma 3 non-catalytic subunit, PRKAG3) isoform plays a role in gene regulation in glucose/lipid metabolism and skeletal muscle glycogen content. We investigated whether PRKAG3, in addition to being expressed in skeletal muscle, is also expressed in human liver. We also investigated whether genetic variance in PRKAG3 is associated with glucose and/or lipid metabolism in non-diabetic whites. MATERIALS AND METHODS: After sequencing a screening cohort (n = 50) in the PRKAG3 locus, we genotyped 1061 participants for frequently found single nucleotide polymorphisms (SNPs). Association analyses between genotypes/haplotypes and metabolic traits were carried out. RESULTS: We detected PRKAG3 expression in human liver and skeletal muscle. Two SNPs (rs692243, rs6436094) with minor allele frequencies of 0.16 and 0.26 respectively and in moderate linkage disequilibrium (D' = 0.92; r (2) = 0.47) were found. rs692243 (C/G) confers a Pro71Ala mutation, while rs6436094 (A/G) is located in the 3' untranslated region. No associations with prediabetic traits such as body fat distribution, insulin resistance or insulin secretion were found (p > 0.15 for all). However, the minor alleles of both SNPs were significantly associated with higher serum LDL-cholesterol and apolipoprotein (Apo) B-100 levels (rs692243: CG:LDL 4.3%, ApoB-100 3.4%; GG:LDL 7.6%, ApoB-100 5.4%; p = 0.008 and p = 0.01 respectively; rs6436094: AG:LDL 3.3%, ApoB-100 1.7%; GG:LDL 11.3%, ApoB-100 11.1%; p = 0.009 and p = 0.05 respectively; dominant model). The GG/GG diplotype homozygous for both minor SNP alleles displayed the highest LDL-cholesterol among all frequent diplotypes (p = 0.059). CONCLUSIONS/INTERPRETATION: While genetic variability in PRKAG3 does not seem to have a major effect on glucose metabolism, it may play an important role in lipoprotein metabolism in humans.


Subject(s)
Genetic Variation , Glucose/metabolism , Lipids/blood , Multienzyme Complexes/genetics , Protein Serine-Threonine Kinases/genetics , AMP-Activated Protein Kinases , Blood Glucose/drug effects , Blood Glucose/metabolism , Cloning, Molecular , DNA, Complementary/genetics , Genotype , Glucose Tolerance Test , Humans , Insulin/metabolism , Insulin/pharmacology , Insulin Secretion , Lipoproteins/blood , Liver/enzymology , Protein Subunits/genetics , Reverse Transcriptase Polymerase Chain Reaction , White People/genetics
9.
Horm Metab Res ; 36(5): 303-6, 2004 May.
Article in English | MEDLINE | ID: mdl-15156410

ABSTRACT

Hepatic lipase hydrolyses triglycerides and phospholipids in all major classes of lipoproteins. The -514C-->T genetic variation in the hepatic lipase gene promoter was found to be associated with diminished lipase activity, dyslipidemia, and atherosclerosis. We investigated whether this polymorphism associates with hyperinsulinemia and insulin resistance in 535 normal glucose-tolerant Germans. Only in homozygous individuals (22 subjects), the T allele (frequency: 18.1 %) was significantly associated with elevated glucose concentrations after 120 min of oral glucose tolerance test (p = 0.05) and with elevated fasting concentrations of insulin (p = 0.03), triglycerides (p < 0.01), total and HDL-cholesterol (p = 0.02), as determined by multivariate linear regression analysis. In a recessive model (C/C+C/T vs. T/T), T/T was associated with decreased insulin sensitivity index (p = 0.03) as calculated from oral glucose tolerance test data (n = 535), but not with the glucose infusion rate during hyperinsulinemic euglycemic clamp (n = 218). In conclusion, we have provided evidence that, among the metabolic parameters tested, the hepatic lipase -514C-->T gene polymorphism correlates with elevated fasting insulin concentrations in a German population. Since no corresponding difference in insulin sensitivity was seen in the clamp-subgroup, an effect of this polymorphism on insulin clearance has to be considered.


Subject(s)
Insulin Resistance/genetics , Insulin/blood , Lipase/genetics , Polymorphism, Single Nucleotide , Promoter Regions, Genetic/genetics , Adult , Arteriosclerosis/genetics , Diabetes Mellitus, Type 2/genetics , Family , Fasting , Female , Germany , Glucose Tolerance Test , Homozygote , Humans , Hyperlipidemias/genetics , Male , Metabolic Clearance Rate
10.
Diabetologia ; 46(7): 956-60, 2003 Jul.
Article in English | MEDLINE | ID: mdl-12827245

ABSTRACT

AIMS/HYPOTHESIS: Adiponectin, an adipocytokine known to be down-regulated in obesity-linked disorders, is considered to be a potential key mediator of insulin sensitivity. In this study, we asked whether adiponectin is able to regulate ten selected genes possibly associated with insulin sensitivity in human skeletal muscle cells. METHODS: To this end, we treated in vitro differentiated human myotubes with the culture supernatant of HEK293 cells stably transfected with human recombinant adiponectin and assessed gene expression by RT-PCR. Intracellular adiponectin protein was quantified by radioimmunoassay and visualized by Western blotting. RESULTS: In contrast to the control supernatant, the adiponectin-containing supernatant consistently induced expression of adiponectin mRNA in human myotubes from eight different donors (mean increase: 90-fold over control; n=8, p<0.001). This increase in mRNA was paralleled by a rise in intracellular adiponectin protein (mean increase: 8.3-fold over control; n=4, p<0.05). Expression of the other nine candidate genes was not altered. In human skin fibroblasts and HepG2 cells, the adiponectin-enriched supernatant did not induce relevant amounts of adiponectin mRNA. CONCLUSIONS/INTERPRETATION: In conclusion, we show here that adiponectin gene expression is specifically inducible in skeletal muscle cells.


Subject(s)
Gene Expression Regulation/genetics , Intercellular Signaling Peptides and Proteins , Muscle Fibers, Skeletal/physiology , Proteins/genetics , Transcription, Genetic , Adiponectin , Adult , Biopsy , Body Mass Index , Cell Line , Cells, Cultured , Coculture Techniques , Female , Humans , Kidney , Male , Muscle, Skeletal/cytology , Muscle, Skeletal/physiology , Proteins/physiology , RNA, Messenger/genetics , Reference Values , Reverse Transcriptase Polymerase Chain Reaction
11.
Endocr Pract ; 6(4): 324-8, 2000.
Article in English | MEDLINE | ID: mdl-11242610

ABSTRACT

OBJECTIVE: To illuminate the natural history of prolonged nephrogenic diabetes insipidus after discontinuation of lithium carbonate treatment and to assess the response to therapy with desmopressin acetate and triamterene-hydrochlorothiazide. METHODS: We analyzed sequential determinations of serum and urine osmolality, plasma arginine vasopressin, serum sodium, blood urea nitrogen, calcium, ionized calcium, parathyroid hormone, and 24-hour urine volume during a period of 57 months in a 67-year-old woman. RESULTS: Our patient experienced persistent polyuria in conjunction with having repeated serum osmolalities between 300 and 323 mOsm/kg and urine osmolalities between 130 and 208 mOsm/kg. Concomitant plasma arginine vasopressin levels were as high as 12.0 pg/mL, consistent with the diagnosis of nephrogenic diabetes insipidus. Administration of triamterene-hydrochlorothiazide reduced 24-hour urine volume and serum osmolality while increasing urine osmolality. Desmopressin acetate exhibited no effect. CONCLUSION: In this report, we describe the eighth documented case of persistent nephrogenic diabetes insipidus, lasting 57 months after cessation of lithium therapy, and demonstrate a palliative effect of triamterene-hydrochlorothiazide.


Subject(s)
Diabetes Insipidus, Nephrogenic/drug therapy , Lithium Carbonate/administration & dosage , Aged , Deamino Arginine Vasopressin/therapeutic use , Diabetes Insipidus, Nephrogenic/pathology , Diuretics/therapeutic use , Female , Humans , Hydrochlorothiazide/therapeutic use , Kidney/pathology , Lithium Carbonate/therapeutic use , Renal Agents/therapeutic use , Sodium Chloride Symporter Inhibitors/therapeutic use , Treatment Outcome , Triamterene/therapeutic use
12.
Toxicology ; 131(2-3): 133-43, 1998 Nov 16.
Article in English | MEDLINE | ID: mdl-9928628

ABSTRACT

Bioactivity-guided fractionation of an alcohol extract of the soft coral Sarcophyton glaucum collected from the intertidal areas and the fringing coral reefs near Hurghada, Red Sea, Egypt resulted in the isolation of a new lactone cembrane diterpene, sarcophytolide. The structure of this compound was deduced from its spectroscopic data and by comparison of the spectral data with those of known closely related cembrane-type compounds. In antimicrobial assays, the isolated compound exhibited a good activity towards Staphylococcus aureus, Pseudomonas aeruginosa, and Saccharomyces cerevisiae. Sarcophytolide was found to display a strong cytoprotective effect against glutamate-induced neurotoxicity in primary cortical cells from rat embryos. Preincubation of the neurons with 1 or 10 microg/ml of sarcophytolide resulted in a significant increase of the percentage of viable cells from 33 +/- 4% (treatment of the cells with glutamate only) to 44 +/- 4 and 92 +/- 6%, respectively. Administration of sarcophytolide during the post-incubation period following glutamate treatment did not prevent neuronal cell death. Pretreatment of the cells with sarcophytolide for 30 min significantly suppressed the glutamate-caused increase in the intracellular Ca2+ level ([Ca2+]i). Evidence is presented that the neuroprotective effect of sarcophytolide against glutamate may be partially due to an increased expression of the proto-oncogene bcl-2. The coral secondary metabolite, sarcophytolide, might be of interest as a potential drug for treatment of neurodegenerative disorders.


Subject(s)
Cnidaria/chemistry , Diterpenes/pharmacology , Neuroprotective Agents/pharmacology , Animals , Calcium/metabolism , Mice , Neuroprotective Agents/isolation & purification , Proto-Oncogene Proteins c-bcl-2/analysis , Rats , Rats, Wistar , Staphylococcus aureus/drug effects
13.
Prenat Diagn ; 9(3): 217-20, 1989 Mar.
Article in English | MEDLINE | ID: mdl-2710746

ABSTRACT

Prenatal diagnosis on chorionic villous tissue was performed for a woman with the karyotype 46,XX,t(2;18)(q32;q12)--a subtle 'difficult' translocation. The case illustrates the necessity of good quality cytogenetics for accurate prenatal diagnosis. For chorionic villi this can be obtained only with long-term culture.


Subject(s)
Chorionic Villi Sampling/methods , Chromosomes, Human, Pair 18 , Chromosomes, Human, Pair 2 , Translocation, Genetic , Female , Humans , Karyotyping , Pregnancy , Time Factors
14.
Nahrung ; 29(1): 87-91, 1985.
Article in English | MEDLINE | ID: mdl-3921846

ABSTRACT

The adaptation of lactic streptococci for growth with their homologous bacteriophage was studied through the addition of bacteriophage filtrate to skim milk medium inoculated with Streptococcus lactis or Streptococcus cremoris. Both S. lactis and S. cremoris attained their adaptability for growth with their homologous bacteriophage after 5 and 2 transferes, respectively, and did not lose it after a storage period of 30 days at 0 degree C.


Subject(s)
Bacteriophages , Lactococcus lactis/growth & development , Animals , Bacteriological Techniques , Culture Media , Filtration , Kinetics , Lactates/biosynthesis , Lactic Acid , Milk/microbiology
15.
Urology ; 22(5): 553-5, 1983 Nov.
Article in English | MEDLINE | ID: mdl-6417871

ABSTRACT

A case of carcinosarcoma of the bladder is presented. The most prominent element in an unusually heterogeneous neoplasm was the chondrosarcomatous element. Despite prompt preoperative radiotherapy and surgical extirpation, local recurrence resulted in death. In this case radiotherapy did not help and delayed surgical removal, thus perhaps adversely affecting the outcome.


Subject(s)
Carcinosarcoma/pathology , Urinary Bladder Neoplasms/pathology , Carcinosarcoma/radiotherapy , Carcinosarcoma/surgery , Combined Modality Therapy , Humans , Male , Middle Aged , Prognosis , Radiotherapy, High-Energy , Urinary Bladder Neoplasms/radiotherapy , Urinary Bladder Neoplasms/surgery
16.
J Immunol ; 118(1): 342-7, 1977 Jan.
Article in English | MEDLINE | ID: mdl-830757

ABSTRACT

Human (but not guinea pig) complement-mediated damage. It was concluded that human complement was activated spontaneously by liposomes containing a high concentration (71 mol %) of cholesterol. This occurred in the absence of any recognizable antigen or antibody, and did not occur at a low concentration (43 mol %) of cholesterol. Activation of complement resulted in membrane damage and release of trapped liposomal glucose. The complement activity was inhibited by preheating (56 degrees C, 30 min), 10 mM Mg2EDTA3 or EGTA, and by prior adsorption with insoluble immune complexes. Almost all human sera had some reactivity, but it ranged from very low levels (less than 7% liposomal glucose release) to very high levels (greater than 50% glucose release). Complement activation appeared to be mediated by a serum factor which could be removed by adsorption and which was partially heat labile. The factor was transferred by adding heated high reacting human serum to unheated low reacting human serum, or to guinea pig serum. The serum factor, although quantitatively diminished in potency due to heat lability, caused equal activation of each of these two latter complement sources in the presence of high cholesterol liposomes. It did not cause activation of C4-deficient guinea pig complement. These data suggested that the classical complement pathway was activated. The liposomal membrane composition had an influence on this phenomenon. Activities of about half of the human sera were enhanced when galactosyl ceramide, or ceramide alone, was present in the liposomes. Activity was enhanced by longer fatty acyl chain lengths of lecithin when dimyristoyl-, dipalmitoyl-, or distearoyllecithin was employed in the liposomes. Liposomes containing sphingomyelin as the only phospholipid were not sensitive to cholesterol-dependent complement-mediated damage. It was concluded that human complement was activated in the presence of high concentrations of membrane cholesterol and that this was caused by an uncharacterized serum factor and was influenced by the lipid composition of the membrane.


Subject(s)
Cholesterol/physiology , Complement System Proteins/metabolism , Liposomes/physiology , Ceramides/pharmacology , Cholesterol/pharmacology , Female , Humans , Male , Membrane Lipids , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL
...